FDA approves weight loss drug Zepbound for sleep apnea - NBC News
Dec 20, 2024 · The Food and Drug Administration expanded the approval of weight loss drug Zepbound to treat obstructive sleep apnea in adults with obesity, the drugmaker Eli Lilly said Friday.
FDA approves weight-loss drug Zepbound for obstructive sleep apnea
Dec 20, 2024 · The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound. The medicine, part of the class known as...
FDA approves weight-loss drug Zepbound to treat sleep apnea
1 day ago · The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but potentially serious sleep-related breathing disorder, making it the ...
GLP-1 Zepbound Is Approved As First Drug For Sleep Apnea - U.S. News …
MONDAY, Dec. 23, 2024 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the...
FDA approves weight loss drug Zepbound to treat sleep apnea : …
Dec 21, 2024 · Sleep apnea occurs when a person's upper airway becomes blocked. While it can affect anyone, it is more prevalent among those who are overweight. The FDA said studies have shown that by...
FDA Approves First Medication for Obstructive Sleep Apnea
Dec 20, 2024 · Today, the FDA approved the first medication for the treatment of moderate to severe obstructive sleep apnea in adults with obesity, to be used in combination with a reduced-calorie diet and ...
F.D.A. Approves Weight Loss Drug to Treat Obstructive Sleep Apnea
Dec 20, 2024 · The Food and Drug Administration on Friday approved the weight loss drug Zepbound to treat obstructive sleep apnea. It is the first prescription medication approved to treat the common sleep...
FDA approves Eli Lilly’s obesity medication for obstructive sleep apnea
Dec 20, 2024 · The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe obstructive sleep apnea for people with obesity.
FDA ApprovesWeight-Loss Drug Zepbound For Sleep Apnea
Dec 20, 2024 · Zepbound, an Eli Lilly drug, can now be prescribed to adults with “moderate-to-severe obstructive sleep apnea and obesity” to improve their sleep, a press release from the company said. Zepbound...
FDA approves weight loss drug Zepbound to treat obstructive sleep apnea
Dec 21, 2024 · The weight loss drug Zepbound has become the first prescription medication approved to treat obstructive sleep apnea. The Food and Drug Administration on Friday authorized the use of Zepbound, made by Eli Lilly & Co., for adults with obesity and moderate to severe obstructive sleep apnea (OSA), a ...